Impact of vaccination on the association of COVID-19 with cardiovascular diseases : An OpenSAFELY cohort study
© 2024. The Author(s)..
Infection with SARS-CoV-2 is associated with an increased risk of arterial and venous thrombotic events, but the implications of vaccination for this increased risk are uncertain. With the approval of NHS England, we quantified associations between COVID-19 diagnosis and cardiovascular diseases in different vaccination and variant eras using linked electronic health records for ~40% of the English population. We defined a 'pre-vaccination' cohort (18,210,937 people) in the wild-type/Alpha variant eras (January 2020-June 2021), and 'vaccinated' and 'unvaccinated' cohorts (13,572,399 and 3,161,485 people respectively) in the Delta variant era (June-December 2021). We showed that the incidence of each arterial thrombotic, venous thrombotic and other cardiovascular outcomes was substantially elevated during weeks 1-4 after COVID-19, compared with before or without COVID-19, but less markedly elevated in time periods beyond week 4. Hazard ratios were higher after hospitalised than non-hospitalised COVID-19 and higher in the pre-vaccination and unvaccinated cohorts than the vaccinated cohort. COVID-19 vaccination reduces the risk of cardiovascular events after COVID-19 infection. People who had COVID-19 before or without being vaccinated are at higher risk of cardiovascular events for at least two years.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Nature communications - 15(2024), 1 vom: 11. März, Seite 2173 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 13.03.2024 Date Revised 25.04.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41467-024-46497-0 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369573293 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369573293 | ||
| 003 | DE-627 | ||
| 005 | 20240425233120.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240312s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41467-024-46497-0 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1386.xml |
| 035 | |a (DE-627)NLM369573293 | ||
| 035 | |a (NLM)38467603 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Cezard, Genevieve I |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of vaccination on the association of COVID-19 with cardiovascular diseases |b An OpenSAFELY cohort study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.03.2024 | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Infection with SARS-CoV-2 is associated with an increased risk of arterial and venous thrombotic events, but the implications of vaccination for this increased risk are uncertain. With the approval of NHS England, we quantified associations between COVID-19 diagnosis and cardiovascular diseases in different vaccination and variant eras using linked electronic health records for ~40% of the English population. We defined a 'pre-vaccination' cohort (18,210,937 people) in the wild-type/Alpha variant eras (January 2020-June 2021), and 'vaccinated' and 'unvaccinated' cohorts (13,572,399 and 3,161,485 people respectively) in the Delta variant era (June-December 2021). We showed that the incidence of each arterial thrombotic, venous thrombotic and other cardiovascular outcomes was substantially elevated during weeks 1-4 after COVID-19, compared with before or without COVID-19, but less markedly elevated in time periods beyond week 4. Hazard ratios were higher after hospitalised than non-hospitalised COVID-19 and higher in the pre-vaccination and unvaccinated cohorts than the vaccinated cohort. COVID-19 vaccination reduces the risk of cardiovascular events after COVID-19 infection. People who had COVID-19 before or without being vaccinated are at higher risk of cardiovascular events for at least two years | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Denholm, Rachel E |e verfasserin |4 aut | |
| 700 | 1 | |a Knight, Rochelle |e verfasserin |4 aut | |
| 700 | 1 | |a Wei, Yinghui |e verfasserin |4 aut | |
| 700 | 1 | |a Teece, Lucy |e verfasserin |4 aut | |
| 700 | 1 | |a Toms, Renin |e verfasserin |4 aut | |
| 700 | 1 | |a Forbes, Harriet J |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Alex J |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Louis |e verfasserin |4 aut | |
| 700 | 1 | |a Massey, Jon |e verfasserin |4 aut | |
| 700 | 1 | |a Hopcroft, Lisa E M |e verfasserin |4 aut | |
| 700 | 1 | |a Horne, Elsie M F |e verfasserin |4 aut | |
| 700 | 1 | |a Taylor, Kurt |e verfasserin |4 aut | |
| 700 | 1 | |a Palmer, Tom |e verfasserin |4 aut | |
| 700 | 1 | |a Arab, Marwa Al |e verfasserin |4 aut | |
| 700 | 1 | |a Cuitun Coronado, Jose Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Ip, Samantha H Y |e verfasserin |4 aut | |
| 700 | 1 | |a Davy, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Dillingham, Iain |e verfasserin |4 aut | |
| 700 | 1 | |a Bacon, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Mehrkar, Amir |e verfasserin |4 aut | |
| 700 | 1 | |a Morton, Caroline E |e verfasserin |4 aut | |
| 700 | 1 | |a Greaves, Felix |e verfasserin |4 aut | |
| 700 | 1 | |a Hyams, Catherine |e verfasserin |4 aut | |
| 700 | 1 | |a Davey Smith, George |e verfasserin |4 aut | |
| 700 | 1 | |a Macleod, John |e verfasserin |4 aut | |
| 700 | 1 | |a Chaturvedi, Nishi |e verfasserin |4 aut | |
| 700 | 1 | |a Goldacre, Ben |e verfasserin |4 aut | |
| 700 | 1 | |a Whiteley, William N |e verfasserin |4 aut | |
| 700 | 1 | |a Wood, Angela M |e verfasserin |4 aut | |
| 700 | 1 | |a Sterne, Jonathan A C |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Venexia |e verfasserin |4 aut | |
| 700 | 0 | |a Longitudinal Health and Wellbeing and Data and Connectivity UK COVID-19 National Core Studies, CONVALESCENCE study and the OpenSAFELY collaborative |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 15(2024), 1 vom: 11. März, Seite 2173 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:11 |g month:03 |g pages:2173 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-024-46497-0 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 |e 1 |b 11 |c 03 |h 2173 | ||